HK51597A - Vaccines for human respiratory virus - Google Patents

Vaccines for human respiratory virus Download PDF

Info

Publication number
HK51597A
HK51597A HK51597A HK51597A HK51597A HK 51597 A HK51597 A HK 51597A HK 51597 A HK51597 A HK 51597A HK 51597 A HK51597 A HK 51597A HK 51597 A HK51597 A HK 51597A
Authority
HK
Hong Kong
Prior art keywords
hrsv
proteins
protein
virus
cells
Prior art date
Application number
HK51597A
Other languages
English (en)
French (fr)
Inventor
Gail W. Wertz
Peter L. Collins
Original Assignee
University Of North Carolina At Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of North Carolina At Chapel Hill filed Critical University Of North Carolina At Chapel Hill
Publication of HK51597A publication Critical patent/HK51597A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)

Claims (4)

  1. Verfahren zum Herstellen eines Impfstoffs gegen menschliches respiratorisches Syncytialvirus, umfassend das Zubereiten von glycosyliertem F-Protein, glycosyliertem G-Protein oder einem Derivat davon mit ausreichender antigener Kapazität, um in einem Patienten, der virulentem HRSV ausgesetzt ist, wirksamen immunologischen Schutz zu erzeugen, das frei von anderem virussynthetisiertem Protein ist, zusammen mit einem geeigneten Träger.
  2. Verfahren nach Anspruch 1, worin der Impfstoff glycosyliertes F-Protein oder ein immunogenes Fragment davon enthält.
  3. Verfahren nach Anspruch 1, worin der Impfstoff glycosyliertes G-Protein oder ein immunogenes Fragment davon enthält.
HK51597A 1986-01-14 1997-04-17 Vaccines for human respiratory virus HK51597A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81874086A 1986-01-14 1986-01-14

Publications (1)

Publication Number Publication Date
HK51597A true HK51597A (en) 1997-04-25

Family

ID=25226293

Family Applications (1)

Application Number Title Priority Date Filing Date
HK51597A HK51597A (en) 1986-01-14 1997-04-17 Vaccines for human respiratory virus

Country Status (7)

Country Link
EP (1) EP0290446B1 (de)
JP (2) JPH01501357A (de)
AT (1) ATE101200T1 (de)
AU (1) AU605476B2 (de)
DE (1) DE3689622T2 (de)
HK (1) HK51597A (de)
WO (1) WO1987004185A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639853A (en) * 1987-09-29 1997-06-17 Praxis Biologics, Inc. Respiratory syncytial virus vaccines
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines
AU2715288A (en) * 1987-11-20 1989-06-14 Upjohn Company, The Human respiratory syncytialvirus vaccine derived from the 1a (9.5 kd) protein
US5194595A (en) * 1987-12-23 1993-03-16 The Upjohn Company Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
EP0540645A4 (en) * 1990-07-24 1993-12-29 The Uab Research Foundation Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells
US6730305B1 (en) 2000-05-08 2004-05-04 The Uab Research Foundation Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins
TW275632B (de) * 1992-04-21 1996-05-11 American Cyanamid Co
FR2726577B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament
FR2726576B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Production de peptides analogues de peptides hydrophobes, peptide recombinant, sequence d'adn correspondante
WO1998002180A1 (en) * 1996-07-12 1998-01-22 Connaught Laboratories Limited Two-step immunization procedure against the pyramyxoviridae family of viruses using attenuated viral strains and subunit protein preparation
US6020182A (en) * 1996-07-12 2000-02-01 Connaught Laboratories Limited Subunit respiratory syncytial virus vaccine preparation
US6180398B1 (en) * 1996-07-12 2001-01-30 Virogeneitics Corporation Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation
US20020136739A1 (en) * 1996-07-12 2002-09-26 Cates George A. Subunit respiratory syncytial virus preparation
AU2001278337A1 (en) * 2000-07-31 2002-02-13 Aventis Pasteur Limited Respiratory syncytial virus vaccine
FR2827605B1 (fr) 2001-07-20 2004-07-16 Pf Medicament Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin
EP4144368B1 (de) 2011-01-26 2025-02-26 GlaxoSmithKline Biologicals S.A. Rsv-immunisierungstherapie
JP7314059B2 (ja) * 2017-05-29 2023-07-25 ザ ユナイテッド ステイツ オブ アメリカ アズ リプリゼンテッド バイ ザ セクレタリー、デパートメント オブ ヘルス アンド ヒューマン サービシーズ Ｒｓｖ ｇを発現する組換えキメラウシ／ヒトパラインフルエンザウイルス３およびその使用法

Also Published As

Publication number Publication date
JPH01501357A (ja) 1989-05-18
DE3689622D1 (de) 1994-03-17
EP0290446A1 (de) 1988-11-17
DE3689622T2 (de) 1994-06-16
EP0290446B1 (de) 1994-02-02
AU605476B2 (en) 1991-01-17
AU6941287A (en) 1987-07-28
WO1987004185A1 (en) 1987-07-16
ATE101200T1 (de) 1994-02-15
JPH08173171A (ja) 1996-07-09

Similar Documents

Publication Publication Date Title
US5716823A (en) Human respiratory virus preparahons and processess
US5194595A (en) Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
EP0290446B1 (de) Impfstoffe gegen menschliche respiratorische viren
US5169628A (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
Wertz et al. Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice
EP0832253B9 (de) Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren
US5993824A (en) Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
DE3856141T2 (de) Respiratorisches syncytiales virus, impstoffe
JP2001517448A (ja) 弱毒化呼吸合胞体ウイルス
EP0484382A1 (de) Felincalicivirus-capsid-protein und nukleotidsequenz.
US6017897A (en) Nucleic acid respiratory syncytial virus vaccines
US5718901A (en) Feline calicivirus gene
JP2002507408A (ja) 麻疹ウイルスもしくはヒト呼吸合胞体ウイルスサブグループｂの弱毒化の原因である突然変異
JP3026986B2 (ja) ヒト・パラインフルエンザウイルス３型の免疫原性セグメント類を含有するキメラ糖蛋白類
WO1997028265A1 (en) Measles immunization by dna transcription unit inoculation
AU2008203034A1 (en) Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20061222